Bioregulator evidence gap: The bioregulator peptide class (epithalon, thymalin, and the broader Khavinson series) faces an evidence gap that is unlikely to close quickly
I schemic stroke/transient ischemic attack : 7.6% vs
Others prefer intermittent approaches: taking medication for 6-12 months, stopping to assess their natural baseline, and restarting if weight regain occurs
MariGold Allulose: Sweetness With Purpose Not all allulose is created equal
I think methylene blue you mentioned is one of those ones where I wouldnt evenI personally wouldnt even take it without testing showing that I need it
Attenuates body mass gain, adipocyte size, and hepatic steatosis in HFD-fed C57BL/6 mice via chemotaxis inhibition, reducing ATM recruitment while increasing CD206 + M2 polarization [175]